ENTA Competitors & Alternatives
Compare Enanta Pharmaceuticals Inc with similar stocks in the same industry
Biotechnology
ENTA
Main Stock$11.44
Tradestie Score
53
Market Cap
$226.82M
Revenue Growth
0.2%
Analyst Upside
+76.1%
Top Competitors
221 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
DRTS
Alpha Tau Medical Ltd. Ordinary Shares
|
$9.67
|
$371.64M | - | 53 | Compare |
|
CAPR
Capricor Therapeutics Inc
|
$26.72
|
$357.51M | - | 56 | Compare |
|
CGEM
Cullinan Therapeutics, Inc. Common Stock
|
$13.61
|
$354.45M | - | 50 | Compare |
|
LBRX
LB Pharmaceuticals Inc Common Stock
|
$28.50
|
$353.70M | - | 56 | Compare |
|
PROK
ProKidney Corp. Class A Ordinary Shares
|
$1.67
|
$350.98M | - | 53 | Compare |
|
ALT
Altimmune, Inc. Common Stock
|
$2.64
|
$341.56M | - | 55 | Compare |
|
ANNX
Annexon, Inc. Common Stock
|
$4.64
|
$332.96M | - | 47 | Compare |
|
REPL
Replimune Group, Inc.
|
$8.96
|
$328.62M | - | 61 | Compare |
|
CADL
Candel Therapeutics, Inc. Common Stock
|
$8.56
|
$304.12M | - | 58 | Compare |
|
JBIO
Jade Biosciences, Inc. Common Stock
|
$16.10
|
$297.23M | - | 49 | Compare |
More ENTA Analysis
Data updated: Jun 15, 2026 | Industry: Biotechnology (SIC 2834)
221 stocks in this industry